Showing results (171-180 of 184) with videos related to
Sort By:
Pageof 19
The Journal of Pharmacology and Experimental Therapeutics|June 12, 2023
Pharmacology of a Potent and Novel Inhibitor of the NOD-Like Receptor Pyrin Domain-Containing Protein 3 (NLRP3) Inflammasome that Attenuates Development of Nonalcoholic Steatohepatitis and Liver FibrosisDavide Povero, Milos Lazic, Christopher McBride, et al.ACS Pharmacology & Translational Science|March 20, 2025
<i>d</i> <sub>4</sub>-Cystamine: A Deuterated Cystamine Derivative with Improved Anti-Inflammatory and Anti-Fibrotic Activities in a Murine Model of Fibrosing SteatohepatitisAleksandra Leszczynska, Thibault Alle, Benedikt Kaufmann, et al.Frontiers in Physiology|March 10, 2022
Cell-to-Cell Communications in Alcohol-Associated Liver DiseaseNatalia A Osna, Akiko Eguchi, Ariel E Feldstein, et al.Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|July 28, 2018
Effects of diets enriched in linoleic acid and its peroxidation products on brain fatty acids, oxylipins, and aldehydes in miceChristopher E Ramsden, Marie Hennebelle, Susanne Schuster, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 4, 2015
Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitisMargarita Pizarro, Nancy Solís, Pablo Quintero, et al.Proceedings of the National Academy of Sciences of the United States of America|August 22, 2024
Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2Souradipta Ganguly, Sara Brin Rosenthal, Kei Ishizuka, et al.Journal of Hepatology|August 9, 2020
Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosisSusanne Gaul, Aleksandra Leszczynska, Fernando Alegre, et al.Pain|July 27, 2013
Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trialChristopher E Ramsden, Keturah R Faurot, Daisy Zamora, et al.Journal of Hepatology|February 8, 2017
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in miceAuvro R Mridha, Alexander Wree, Avril A B Robertson, et al.Nature|April 9, 2011
Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseZeneng Wang, Elizabeth Klipfell, Brian J Bennett, et al.Pageof 19